Kimanin wata daya da suka wuce, AliveCor yayi ƙoƙari don hana aikin ECG na Apple Watch a Amurka. Ya yi zargin zargin keta doka. Yanzu yana tafiya mataki daya gaba kuma ya yi ƙarar kamfanin Ba'amurke da keɓaɓɓe. Dalilin kuwa shine cewa Apple ya cire masu samarda bincike na zuciya na uku daga Apple Watch kuma hakan ya cutar da AliveCor.
A cewar kamfanin AliveCor, shawarar Apple na cire masu samar da binciken bugun zuciya na wani daga Apple Watch ya cutar da kamfanin kuma ya shafi marasa lafiya da masu sayayya. AliveCor ya ƙirƙiri aikace-aikacen SmartRhythm, ta amfani da bayanai daga Apple Watch zuciya na algorithm. Wannan yana taimakawa wajen tantance lokacin da bugun zuciya ba shi da tsari kuma yana ba da shawarar cewa su ɗauki bugun bugun bugun bugun su tare da ɗayan kayan sa, KardiaBand
KardiaBand ya sami izinin FDA a cikin 2017, kuma a cikin 2018, Apple ya gabatar da Apple Watch Series 4 tare da damar ECG ginannen ciki da kuma sanarwar rashin bugun zuciyar ka. AliveCor yayi ikirarin cewa Apple ya lura da nasarar KardiaBand kuma ya canza ayyukan watchOS don lalata ta. Kuma ta waccan hanyar, don samun damar mallakan kasuwar binciken bugun zuciya a cikin Apple Watch.
Kamfanin mai shigar da kara ya ce da farko an ba da izinin SmartRhythm app a App Store, amma daga baya Apple ya ce ya keta ka'idojin Store Store. Sun kara zargin cewa Apple "yayi canje-canje ga ajiyar zuciya a cikin algorithm" don tabbatar da hakan gasa apps ba zai yi aiki ba.
5 masu kallo bai inganta kwarewar mai amfani ba. Koyaya hana wasu kamfanoni gano rashin daidaiton yanayin bugun zuciya. Saboda haka, sun miƙa aikace-aikacen da zasu iya gasa da agogon kamfanin.
Wata fitina kuma ga apple cewa ta saba da shi ga irin wannan taron.